Is Organogenesis Holdings Inc. overvalued?

Organogenesis Holdings Inc. (ORGO) looks overvalued — trading about 54% above its fair value.

Overvalued

Price

$1.79

Fair value

$0.82

Current P/E

59.7

Normal P/E

27.5

Market cap

$230.3M

Dividend yield

0.0%

Return on equity

-24.2%

Sector

Healthcare

Fair value compares ORGO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks